General MedicationsINHALATIONGeneric

IPRATROPIUM BROMIDE

Standard Dose

0.02%

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 207903 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient IPRATROPIUM BROMIDE Form and strength SOLUTION;INHALATION - 0.02% Sponsor SUN PHARM Submission history Latest submission status date: 2024-11-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 207903 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IPRATROPIUM BROMIDE Form and strength SOLUTION;INHALATION - 0.02% Sponsor SUN PHARM Submission history Latest submission status date: 2024-11-19 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.